imatinib
Phase 2- Indications
- Acute Respiratory Distress Syndrome (ARDS), COVID-19-associated ARDS
Company intelligence / Profile preview
Exvastat Ltd
Cambridge, England, United Kingdomexvastat.com ↗
- Ownership
- Private
- Employees
- ~4
- Development stage
- Phase 2
01
Overview
Exvastat Ltd was a UK-based single asset biopharmaceutical company founded in 2016. The company focused on developing Impentri™, an intravenous formulation of imatinib targeting acute respiratory distress syndrome (ARDS), a condition with significant unmet medical need and no approved pharmaceutical therapies. The product showed promise in human case reports and animal models. Exvastat coordinated the IMI-funded Impentri consortium involving academic partners such as Vrije Universiteit Medical Center and AMC Amsterdam. As of the latest records, Exvastat Ltd has been dissolved.
- Therapeutic areas
- OtherPulmonology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
IMI Innovative Medicines Initiative consortium partners including Vrije Universiteit Medical Center Amsterdam UMC and Simbec-Orion for clinical trial management
Beyond the preview
Go deeper on Exvastat Ltd.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exvastat Ltd.